RBC Capital raised the firm’s price target on Leidos to $120 from $105 and keeps a Sector Perform rating on the shares. The company’s Q4 results were strong, led by the Health segment, the analyst tells investors in a research note. Leidos is exiting 2023 with momentum in its markets, and sentiment on the stock has improved substantially as the results have surprised to the upside, the firm added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on LDOS:
- Leidos Holdings Inc Is Worried About This – Should You Be Worried Too?
- Leidos Holdings Unveils New Segment-Based Financial Structure
- Leidos sees FY24 EPS $7.50-$7.90, consensus $7.60
- Leidos Holdings, Inc. Reports Fourth Quarter and Fiscal Year 2023 Results
- Leidos reports Q4 EPS $1.99, consensus $1.74